Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CELive EventsScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Rapid Readouts

Rapid Readouts: The SOLO2 / ENGOT Ov-21 Trial

ByKathleen N. Moore, MD, Stephenson Cancer Center
June 25th 2020

Rapid Readouts: Three-Year Update From CheckMate 227, Part 1

BySuresh S. Ramalingam, MD, FASCO, Winship Cancer Institute of Emory University
June 23rd 2020
Advertisement

Rapid Readouts: Final Analysis of KEYNOTE-189

ByEdward Garon, MD, Jonsson Comprehensive Cancer Center at UCLA
June 23rd 2020

Rapid Readouts: Update of CARTITUDE-1

BySaad Z. Usmani, MD, FACP, Levine Cancer Institute
June 23rd 2020

Rapid Readouts: The TIVO-3 Study of Tivozanib in Metastatic Renal Cell Carcinoma

BySumanta K. Pal, MD, City of Hope Comprehensive Cancer Center
June 19th 2020

Rapid Readouts: CheckMate 9LA

ByMartin Reck, MD, PhD, Lung Clinic Grosshansdorf
June 16th 2020
Advertisement

Rapid Readouts: JAVELIN Bladder 100 Phase III Interim Analysis

ByPetros Grivas MD, PhD
June 16th 2020
  • Prev
  • 1
  • More pages
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Prev
Advertisement
Advertisement

Trending on OncLive

1

FDA Approves Neladalkib for Locally Advanced or Metastatic ALK+ NSCLC

2

FDA Removes Limitations of Use for Liso-Cel in Primary Central Nervous System Lymphoma

3

FDA Accepts sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis

4

Beyond the Target: Payloads, Therapeutic Windows, and Biomarkers Shape the Next Wave of ADCs in NSCLC

5

Sintilimab Receives Positive CHMP Opinion for First-Line Nonsquamous NSCLC

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us